Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
15.6%
% of XLV's 64 holdings also in PJP
41.7%
% of PJP's 24 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.7% | 6.7% | 6.7% |
|
JOHNSON & JOHNSON | 7.5% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 5.3% | 6.0% | 5.3% |
|
ABBVIE INC | 5.0% | 5.9% | 5.0% |
|
ABBOTT LABORATORIES | 3.7% | 6.1% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 10.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
ELI LILLY & CO | 3.0% |
|
DANAHER CORP | 3.0% |
|
ANTHEM INC | 2.3% |
|
INTUITIVE SURGICAL INC | 2.3% |
 |
MEDTRONIC PLC | 2.1% |
|
BRISTOL-MYERS SQUIBB CO | 2.1% |
|
STRYKER CORP | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.9% |
XLV Underweight Relative to PJP
|
GILEAD SCIENCES INC | -4.3% |
|
AMPHASTAR PHARMACEUTICALS INC | -3.9% |
|
UNITED THERAPEUTICS CORP | -3.8% |
 |
TARO PHARMACEUTICAL INDUS | -3.8% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.7% |
|
AMGEN INC | -3.5% |
|
LIGAND PHARMACEUTICALS-CL B | -3.4% |
|
JAZZ PHARMACEUTICALS PLC | -3.3% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
|
GERON CORP | -3.2% |